Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research
Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structu...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Journal of Responsible Innovation |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/23299460.2024.2316363 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841556112256532480 |
---|---|
author | Zainab Afshan Sheikh Helen Yu |
author_facet | Zainab Afshan Sheikh Helen Yu |
author_sort | Zainab Afshan Sheikh |
collection | DOAJ |
description | Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation. |
format | Article |
id | doaj-art-a59a4ead697546999a7dfeabfa28189d |
institution | Kabale University |
issn | 2329-9460 2329-9037 |
language | English |
publishDate | 2024-12-01 |
publisher | Taylor & Francis Group |
record_format | Article |
series | Journal of Responsible Innovation |
spelling | doaj-art-a59a4ead697546999a7dfeabfa28189d2025-01-07T13:48:20ZengTaylor & Francis GroupJournal of Responsible Innovation2329-94602329-90372024-12-0111110.1080/23299460.2024.2316363Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery researchZainab Afshan Sheikh0Helen Yu1Faculty of Law, Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen, Copenhagen, DenmarkDepartment of Public Health, Center for Medical Science and Technology Studies, University of Copenhagen, Copenhagen, DenmarkEnsuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.https://www.tandfonline.com/doi/10.1080/23299460.2024.2316363Responsible Research and Innovationstakeholder engagementdrug discoveryscience-society relationssemi-structured interviews |
spellingShingle | Zainab Afshan Sheikh Helen Yu Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research Journal of Responsible Innovation Responsible Research and Innovation stakeholder engagement drug discovery science-society relations semi-structured interviews |
title | Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research |
title_full | Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research |
title_fullStr | Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research |
title_full_unstemmed | Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research |
title_short | Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research |
title_sort | perspectives of copd patients publicly funded scientists and industry representatives on responsibility and stakeholder engagement in drug discovery research |
topic | Responsible Research and Innovation stakeholder engagement drug discovery science-society relations semi-structured interviews |
url | https://www.tandfonline.com/doi/10.1080/23299460.2024.2316363 |
work_keys_str_mv | AT zainabafshansheikh perspectivesofcopdpatientspubliclyfundedscientistsandindustryrepresentativesonresponsibilityandstakeholderengagementindrugdiscoveryresearch AT helenyu perspectivesofcopdpatientspubliclyfundedscientistsandindustryrepresentativesonresponsibilityandstakeholderengagementindrugdiscoveryresearch |